The effect of vitamin E and docosahexaenoic acid ethyl ester on Metabolic Dysfunction-Associated steatotic Liver Disease (MASLD)-A randomised, double-blind, placebo-controlled, parallel-group clinical trial (PUVENAFLD).
Naim AlkhouriDeanna McCarthyAnne-Cécile V BayneTraci BlonquistKarin Yurko-MauroRaj K VuppalanchiEric LawitzNaga P ChalasaniPublished in: Alimentary pharmacology & therapeutics (2024)
The combination of DHA + vitamin E or either agent alone did not demonstrate efficacy on reducing liver fat or aminotransferases in the studied population.